Peter Pitts is President and co-founder of the Center for Medicine in the Public Interest. He previously worked for the U.S. Food and Drug Administration as an associate commissioner, a policy advisor, and a supervisor of the FDA’s Office of Public Affairs, Office of the Ombudsman, Office of Special Health Issues, Office of Executive Secretariat, and Advisory Committee Oversight and Management. He served on the agency’s obesity working group and counterfeit drug taskforce. His book, Become Strategic or Die, is widely recognized as a cutting edge study of how leadership, in order to be successful over the long term, must be combined with strategic vision and ethical practice. He is the editor of the new book, Coincidence or Crisis, a discussion of global prescription medicine counterfeiting. He has served as an adjunct professor at Indiana University’s School of Public and Environmental Affairs and Butler University.
Seeking Clarity on Drug Pricing
Health and Human Services Secretary Alex Azar wants to make prescription drug pricing more transparent. We agree.
2006 State Legislators Desktop Reference to Prescription Drug Policy
Legislators need to be prudent stewards of taxpayer dollars, but they must also ensure that vulnerable populations receive appropriate care. This Desktop Reference will help state legislators identify effective actions that may save the state money without reducing access to needed medicines. Topics include Medicaid restrictive formularies, importation/reimportation, purchasing coalitions, drug price controls, tort reform, counterfeit drugs, and direct-to-consumer advertising.
Total Records: 2